Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Phase 2EnobosarmSemaglutidePositive

AI Analysis

Summary

Veru announced full enrollment completion for the Phase 2b PLATEAU clinical trial evaluating the combination of enobosarm and semaglutide for high quality weight loss.

Clinical Trial Data

Phase

Importance:5/10

Sentiment:

0.50

Phase 2benrollmentcombination therapyweight lossPLATEAU trial

Related Companies

$VERU

Read the original article

Published by yahoo_finance on July 27, 2026 12:10 PM

Read Original